⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Anticholinergic Exposure and Cognitive Risk
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-20 — Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer’s Disease: Brain Safe trial launch: 700-person, 12-month RCT of a consumer deprescribing app vs. attention-control medication-list app in older adults, powered to test reduction in strong anticholinergic exposure (trial description, no results yet). [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease
20-jul-2026
novelty 3
per-area 3
strengthens